Lucid Diagnostics Other Current Liabilities

Lucid Diagnostics posts a other current liabilities of $2.2M as of March 2026. That compares with $34B in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Lucid Diagnostics's other current liabilities was $34B. The latest reading is $2.2M — a 100.0% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Lucid Diagnostics's financial statement story. At $2.2M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LUCD's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Lucid Diagnostics's other metric pages and overview cover the third.